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1. Introduction
3D optical imaging for large (>0.5 cm3) intact samples is an
increasingly utilized tool in many areas of biomedical research,
driven by the desire to understand the 3D structure of biological
systems across multiple biological length scales. All 3D optical
microscopy techniques aiming to image large samples must
overcome the opacity of the tissue to visible light caused by scat-
ter and absorption; tissue clearing and serial-sectioning are two
of the most common approaches. Tissue clearing renders tissue
optically transparent through delipidation
and refractive index matching,[1–3] thus
enabling visible light to penetrate large
(several centimeters) samples fully.
Serial-sectioning physically cuts the sam-
ple, exposing the deeper tissue layers and
removing the need for visible light to
penetrate the tissue. Cleared samples can
be imaged using techniques such as light-
sheet microscopy[2,4] and optical projection
tomography (OPT).[3,5] While clearing has
been successfully applied to many organs
and tissues, the plethora of different proto-
cols can be daunting for new users and a
researcher must carefully consider the
trade-off associated with each method,
e.g., effectiveness of tissue clearing
(particularly for large organs) verses stain
preservation (endogenous fluorescence
and lipophilic dyes), morphological
changes, time, and complexity.[6–8]
In serial-sectioning, samples are embed-
ded in a hard supporting material, such as
resin or paraffin, forming a block. Serial
sections can then either be cut, mounted,
stained, and individually imaged, or imaging and sectioning
of the block face can be interleaved (i.e., an image of the block
face taken after each successive section is cut). For the former
approach, the 3D alignment of the images is a nontrivial
challenge due to the significant distortions and misalignments
that occur during sectioning and subsequent processing.[9]
In contrast, the second approach, serial-section block-face
(SSBF) imaging, produces inherently aligned images, thereby
overcoming the slice alignment challenge and preventing the
potential loss of data through sections damaged during cutting.
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3D microscopy of large biological samples (>0.5 cm3) is transforming biological
research. Many existing techniques require trade-offs between image resolution,
sample size, and method complexity. A simple robust instrument with the
potential to conduct large-volume 3D imaging currently exists in the form of the
optical high-resolution episcopic microscopy (HREM). However, the develop-
ment of the instrument to date is limited to single-fluorescent wavelength
imaging with nonspecific eosin staining. Herein, developments to realize the
potential of the HREM to become multifluorescent high-resolution episcopic
microscopy (MF-HREM) are presented. MF-HREM is a serial-sectioning and
block-facing wide-field fluorescence imaging technique, which does not require
tissue clearing or optical sectioning. Multiple developments are detailed in
sample preparation and image postprocessing to enable multiple specific stains
in large samples and show how these enable segmentation and quantification of
the data. The application of MF-HREM is demonstrated in a variety of biological
contexts: 3D imaging of whole tumor vascular networks and tumor cell invasion
in xenograft tumors up to 7.5 mm3 at resolutions of 2.75 μm, quantification of
glomeruli volume in the adult mouse kidney, and quantification of vascular
networks and white-matter track orientation in adult mouse brain.
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However, SSBF requires whole-mount staining (similar to
light-sheet imaging) and suffers a loss of axial resolution, due
to contamination of the image plane by out-of-focus light from
below the block’s surface (subsurface fluorescence).[10,11] The
addition of optical-sectioning capabilities, such as two-photon
and structured illumination to SSBF instruments, has largely
overcome the subsurface fluorescence issue[12–15] but at the cost
of dramatically increasing such instruments’ complexity and
technical specification. These instruments are highly complex,
predominantly custom built, and require extensive expertise to
align and maintain.[12,15] This puts SSBF imaging beyond the
reach for the majority of biomedical researcher labs and thus cre-
ates a niche for a technically simpler SSBF imaging technique for
cases where a clearing-based approach is impossible or undesir-
able. A commercially available SSBF system, the Optical HREM
(Indigo Scientific), has been in existence for several years and
robust protocols for its use are well established.[16] The system
(Figure 1A) comprises a compound microscope head
Figure 1. A) The HREM instrument consists of a fluorescent microscope with 1 objective lens (NA:0.25) and a variable zoom which provides fields
of view ranging from 25mm down to 2.3 mm. Biological samples are held within a removable sample holder under the microscope objective on a
z-translational stage to enable sections to be cut with a horizontally aligned, automated sectioning blade. Single-use tungsten carbide blades allow large
samples to be cut. The sample is illuminated by a mercury vapor lamp, with separate excitation and emission filters for multiple-wavelength imaging.
B) Single slices are inherently aligned leading to simple 3D volume rendering of xenograft tumor model. Vascular network as stained by i.v-administered
lectin and injected cells (stained via themedium-term cell-tracing dye CM-DiI) can be clearly identified. C) TheMF-HREM sample preparation, acquisition,
and image postprocessing timeline for a typical multistained sample. For animal models, the sample is collected following perfusion fixation; in some
cases, the sample is stained in vivo, prior to fixation. The sample is fixed overnight in paraformaldehyde (PFA) before being whole-mount stained (small
mount stain or antibody). As almost all candidate resins are immiscible with water, samples must be dehydrated before polymerization. Once staining is
complete, the sample is dehydrated using a series of organic solvents, followed by infiltration with a three-part glycol methanlacrylate acrylic (GMA) resin.
Finally, the sample is set within the final resin block in the desired orientation and attached to a chuck for mounting to the instrument. Sample imaging
with multiple wavelength channels is automated. D) A demonstration of the three HREM imaging methods, utilizing different sources of contrast, in
xenograph tumor models. Optical HREM derives’ contrast from positive, nonspecific eosin staining. Tissue autofluorescence provides contrast in EFIC.
MF-HREM uses multichannel fluorescence labeling to visualize multiple specific cellular targets simultaneously.
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(Olympus MVX10) (as widely used in various light-sheet
setups),[2] a light source (LED or arc lamp) with a polychromatic
mirror, and an excitation and emission filter wheel for wave-
length selection. A charge-coupled device (CCD) camera (users’
choice) records images after each section. The key feature of the
system is the inbuilt automated microtome and software inter-
face for alternate block-face fluorescent imaging and thin section
cutting (down to 0.86 μm).
The Optical HREM instrument and methods were originally
developed as a platform for phenotypingmousemodels[17–22] and
have since been more widely applied.[23–25] The main limitation
in its use to date has been the absence of protocols and tools for
using multiple targeted contrast agents. The vast majority of
HREM to date has utilized a negative-contrast eosin approach
(via the property of eosin, when bound to eosinophilic proteins,
to inhibit the fluorescence of unbound eosin in the embedding
resin). This produces images with an appearance similar to the
inverse of traditional eosin staining in histology (Figure 1D). One
exception has been the use of nonfluorescent resin with native
autofluorescence.[26] This autofluorescence approach (termed
episcopic fluorescence image capture (EFIC)) was tested on
mouse embryos but does not have potential to target specific
structures or multiplex stains (Figure 1D). Moreover, the resolu-
tion using autofluorescence is far coarser than the eosin staining
approach, as no postprocessing solutions to recover the axial res-
olution have been developed.[26]
Seeing the potential for this instrument in the 3D imaging
field, we have developed the necessary sample preparation tech-
niques and an axial resolution postprocessing method to enable
dual fluorescent labeling, multichannel imaging, and quantifica-
tion of specific biological structures in tissue samples >0.5 um3,
at resolution up to 2.75 μm using the Optical HREM instrument
(Figure 1B). In this article, we present the optimization of the
MF-HREM methodology, including stain penetration and resin
embedding. We also describe a two-stage approach to recovering
axial resolution, first using an opacifying agent (orasol black
[OB]) to limit light transmission into the sample and second
using deconvolution in postprocessing with a point-spread-
function (PSF) estimated from the image stack itself.
Finally, we demonstrate the wide applicability of MF-HREM by:
1) quantifying glomeruli volume in adult mouse kidneys; 2) seg-
menting vascular networks and invasive cells in a mouse tumor
xenograft model; and 3) segmenting vascular networks and quan-
tifying white-matter tract orientation in a mouse brain. We show
here that these developments greatly broaden the potential
applications of HREM and provide a large-volume 3D imaging
platform that is accessible to a wide range of researchers.
2. Results
2.1. Optimization of Sample Preparation
The pipeline for MF-HREM is straightforward and does not
require specialist equipment (Figure 1C). Each stage of the pipe-
line requires optimization for a specific experiment (organ and
stain combination) and we have conducted these optimizations
for a variety of adult mouse organs and experimental conditions.
These optimized protocols can serve as a starting point for other
experimental conditions and demonstrate the breadth of poten-
tial applications for MF-HREM.
2.1.1. Staining
As MF-HREM requires whole-mount staining prior to dehydra-
tion and resin infiltration, stain compatibility with the process
must be established. We have tested a wide variety of stains
and assessed their compatibility with various dehydrants and res-
ins. We have particularly focused on providing robust counter-
stains for cell nucleus (HCS Nuclear Mask [NM]), cytoplasm
(HCS Cell Mask [CM]) and cells membrane (Wheat Germ
Agglutinin), as well as for vascular-staining lectin–dyelight con-
jugate (a full list of stains can be found in Table S2, Supporting
Information). It is noteworthy that the lipophilic stain, CMDiI, is
compatible with MF-HREM where it is not with many clearing
techniques.[7]
Whole-mount staining requires homogenous and rapid stain
penetration, which can be improved by increasing tissue perme-
ability. Four methods to increase the permeability of tissue sam-
ples that have been previously used[1,5,27,28] were compared:
freeze-thaw method, proteinase K (P[K]) digestion, iDISCO
(which combines several mild detergents),[1] and saponin. The
comparison of the four methods on adult mouse kidneys showed
that saponin treatment significantly increased stain penetration,
compared with the control case (p¼ 0.04) (paired t-test N¼ 4).
The iDISCO method also increased stain homogeneity
(p¼ 0.055) compared with control kidneys (Figure 2AC).
Alternative staining routes, such as intravascular (i.v.) injec-
tion, are also compatible with MF-HREM in animal models.
For vascular staining, use of i.v. injection of fluorescently conju-
gated lectins is effective with the MF-HREM pipeline across a
range of organs, as shown in Figure 5–7.
2.1.2. Resin Infiltration and Embedding
After staining, samples must be dehydrated and embedded in
resin to provide mechanical stability during sectioning.
Various commercial resins are used in histology, however, as
these resins are designed to be manually cut and subsequently
stained; they are not optimized for automated, thin sectioning,
fluorescence preservation, or, in many cases, large samples.[29]
We investigated the compatibility of five commercial resins,
which covered the three broad chemical categories for hard res-
ins: methacrylate resins (Technovit 7100, Technovit 8100, and
Lowicryl HM20), epoxy resin (Spurr), and acrylic resins (LR
White).[29–31] Resins were assessed for the time taken to set
(quantitative), their compatibility with an opacifying agent OB
(binary) (see Section 2.2.1 for further details), for their cut quality
(semiquantitative) and for hardness (quantitative).
Technovit 8100 provided the best combination of cut quality,
hardness, time to set, and compatibility with OB (Figure S1 and
Table S3, Supporting Information). The addition of OB to
Technovit 8100 showed that resin hardness decreased with
increasing concentrations of OB and that this could be counter-
acted by increasing the concentration of the resin’s secondary
catalyst (Figure S1, Supporting Information).
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Finally, infiltration/embedding times for a variety of adult
murine tissues were optimized to provide protocols for differ-
ently sized organs (Table 1).
2.2. Minimizing Subsurface Fluorescence
2.2.1. Minimizing Subsurface Fluorescence with OB
In any wide-field microscopy technique, fluorophores that are
above or below the focal plane may be excited and their emission
captured as out-of-focus light at the focal plane (Figure 3A). For
MF-HREM and other SSBF techniques, this effect is asymmetric
due to the physical sectioning of the sample above the focal
plane. This leads to a characteristic comet tail-like artifact in
the axial plane, which prevents image segmentation. To reduce
this so-called subsurface fluorescence, opacifying agent (OB)
may be added to the embedding resin. OB reduces the penetra-
tion of incident light into the block and absorb emitted photons
from beneath the block’s surface, thus reducing subsurface
fluorescence.[32]
The extent to which OB reduces subsurface fluorescence is
wavelength dependent. The transmission spectrum of OB is
shown in Figure 3B. It has a broad absorption from the
450 nm to 650 nm range, with a steep increase in transmission
in the near-infrared range (>700 nm). We have previously shown
the decrease in subsurface fluorescence with increasing OB
concentration at wavelengths of 705 nm.[11] When conducting
MF-HREM, the wavelength-dependent absorption of OB as well
as the type of structure and the staining intensity must be
considered.
Figure 2. Optimization of stain penetration in adult mouse kidney samples. Four methods for improving stain penetration are compared: saponin
treatment, proteinase [K] digestion, freeze-thaw, and iDISCO. For each method, four treated and four control kidneys were investigated, with one kidney
from each animal used as a control for the contralateral kidney. A) Representative images of the kidneys, imaged as described in Section 5.2, alongside the
control (contralateral kidney on the left and the treated kidney on the right) (scale bar: 1 mm). B) The normalized MF-HREM signal intensity profile as a
function of radial distance from the kidney edge. C) The fractional area of the kidney section image, above a threshold value (the same threshold was used
for each treated kidney and matched control using default thresholding in ImageJ). Results of the paired t-test analysis demonstrate that saponin treat-
ment significantly increased stain penetration (p< 0.05).
Table 1. Optimization of dehydration and embedding times for samples or various sizes.
Reagent >60 mm3 Embryo (up to E12.5)
organoid or 3D culture
60400 mm3, e.g., sciatic
nerve or embryo E14.5 to P1
0.41 cm3, e.g., heart,
kidney, brain, tumor
>1 cm3
Acetone 50% 1 h 6 h 12 h 24 h (refresh at 12 h)
Acetone 70% 1 6 h 24 h (refresh at 12 h) 24 h (refresh at 12 h)
Acetone 80% 1 h 2 h 2 h 12 h (refresh at 6 h)
Acetone 100% 15min 3 1 h 3 2 h 3 3 h 3
50:50 Acetone: infiltration sol 2 hrs 12 hrs 12 h 24 h
25:75 Acetone: infiltration sol. NA 12 h 12 h 24 h
100% Infiltration sol. þ vacuum 2 h include OB 12 h include OB 24 h (refresh at 12 h) include
OB after refresh
48 h (refresh at 24 h) include
OB at refresh
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Figure 3B shows the transmission spectrum of two commer-
cial counterstains HCS CM (a cytoplasm stain) and HCS NM
(a nuclear stain). The CM spectrum falls almost entirely within
the low-transmission band of OB, whereas the emission of NM
falls in the section of steep increase in transmission.
Representative images in Figure 3C,D and the intensity profile
plots in Figure 3E show the more pronounced comet tail arti-
fact in the NM case than the CM case for the same concentra-
tion of OB (16 mgmL1). Figure 3F,G quantifies this
difference, showing that the exponential decrease in intensity
through the z plane has a significantly lower decay constant for
NM than CM. Initial intensity I0 and R2 values are also signif-
icantly lower for NM than CM (Figure 3G), indicating the
reduced signal-to-noise ratio for NM at this high OB concen-
tration (16 mgmL1). While these data demonstrate that a
greater reduction in subsurface fluorescence can be achieved
when using fluorophores fully within the absorption spectrum
of OB, other considerations must be factored in: the concen-
tration of OB will also reduce the signal-to-noise ratio to dif-
ferent degrees, depending on the intensity of the stain used
and the structure stained, and at high concentrations, OB
interferes with resin setting. When conducting MF-HREM,
Figure 3. Characterization of OB as an opacifying agent to reduce shine through with multiple fluorophores. A) Diagram demonstrating the origin of
shine through. B) Graph showing the measured transmission spectrum of OB (0.1 mgmL1, 4 mm path length), as well as two tested commercial stains
HCS NM and HCS CM (spectrum from manufacturer) (adapted from the study by Walsh et al.[11]). OB has low transmission in the 400625 nm range,
which increases steeply in the 625700 nm range. The CM spectrum falls almost entirely within the low-transmission band of OB, whereas the emission
of NM falls in the section of steep increase in transmission. C,D) Representative images of cells in an in vitro 3D culture stained with NM (C) and CM (D)
with 16mgml1 of OB. The comet tail artifact can be seen in the xz plane image particularly for NM, (scale bar¼ 200 μm). E) Line profiles from C and D.
The longer comet tail in the case of NM can be seen more clearly here, as can the lower signal-to-noise ratio for NM. F) A single-exponential fit to the
mean intensity profiles for ten region of interest (ROIs) (xz plane) taken of single cells in the cultures stained with NM and CMwith 16mg/ml of OB (inset
shows the same data normalized to initial intensity). E) Boxplots for the fit constants of the ten ROIs for CM and NM: exponential decay constant (λ),
initial intensity (I0), background (c), and R
2 values. As expected from the transmission spectrum, NM has a significantly lower decay constant (p¼ 0.025).
In addition, the lower signal-to-noise ratio seen in (E) is quantified by the lower the I0 of NM compared with CM (p¼ 2 105) and the lower R2 values
(p¼ 0.035).
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the choice of OB concentration used must balance the require-
ments of minimizing subsurface fluorescence, achieving ade-
quate signal-to-noise for image processing, and optimum
resin setting. The wavelength-dependent OB absorbtion, rela-
tive intensities of multiple stains, and image segmentation
goals will all have to be considered. In the example applica-
tions we present here, OB concentrations between 1 and
4 mgmL1 were found to be optimal depending on the struc-
tures imaged and fluorophores used (see Section 3 and
Table S1, Supporting Information).
2.2.2. Minimization of Shine-through Artifact with Image Post
Processing
As OB cannot be used to entirely eliminate subsurface fluores-
cence, we applied a postprocessing method developed to decon-
volve signal from SSBF modalities and enable segmentation.[11]
Briefly, the method uses structures from within the image stack
to estimate the parameters of a synthetic asymmetric PSF. This
PSF is used to deconvolve the image, and a priori geometric con-
straints of the structures (e.g., the orthogonality of blood
Figure 4. A) The pipeline for the extraction of a PSF from an image stack of a subcutaneous tumor with microvascular stained via injection of Lectin-
Dyelight649. Suitable point-like sources are found in the image stack, cropped from the image, and line profiles are used to fit σxy and σz. A synthetic PSF is
created with these parameters.[61] This PSF is then half zeroed to create the final PSF. B) Application of the PSF estimation and deconvolutionmethod to a
whole tumor vascular network improves axial resolution. C) Application of the PSF estimation and deconvolution method to a whole tumor cell distribu-
tion image improves axial resolution.
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vessels) are used to optimize the iteration number for a
Richardson–Lucy (RL) deconvolution.[11] Using a tilling approach
with graphics processing unit (GPU) deconvolution enables full-
size MF-HREM images to be deconvolved efficiently and
decreases the comet tail artifact to allow segmentation in many
cases (Figure 4).
Measurements of the full width half maximum (FWHM) for
small structures were used to parameterize a synthetic PSF
model (Figure 4A).
A synthetic PSF was created using either the Gibson and
Lanni Model or Gaussian model depending on pixel size. This
model was parameterized from the mean measured FWHM
(Gibson and Lanni) or standard deviation (Gaussian) of several
selected small structures (Figure 4A) (as described in the study by
Walsh et al.[11]). The lower half of the synthetic PSF was zeroed to
replicate the asymmetry caused by serial-sectioning. This
approach provides the practical advantages of using the image
stack for PSF estimation, with the benefit of synthetic signal-
to-noise ratio.[33,34] The asymmetric PSF was then incorporated
into the widely used Richardson–Lucy deconvolution algorithm,
an iterative method implemented in many open-source software
repositories.[10,35] This approach was applied to image stacks of
different magnifications, wavelengths, and concentrations of OB
(see Table S1, Supporting Information, for imaging parameter
values). In all cases there is improvement in axial resolution
and in the case of higher OB concentration and high magnifica-
tion, the approach successfully enables segmentation of large
vascular networks (Section 3.2). For lower concentration of
OB and lower magnification (Figure 4B,C), our approach enables
automated quantification of subsections of the image
(Section 3.2) and improves the comet tails’ artifact appearance.
3. Applications
3.1. Glomeruli Number and Volume in Adult Mouse Kidney
The nephron is the microscopic structural unit of the kidney,
comprising two parts: the renal tubule and renal corpuscle.
The renal corpuscle contains a cluster of capillaries known as
a glomerulus. Nephron number has been used in both human
and animal models as a biomarker of both renal and cardiovas-
cular disease.[36] However, the total nephron number and glo-
merulus size are challenging to estimate from 2D sectioning
techniques. Figure 5 shows an adult mouse kidney stained with
a vascular marker, prepared and imaged using our MF-HREM
pipeline. Glomeruli were segmented in the final image stack.
MF-HREM pixel size was 2.17 μm lateral, or “in plane,” and
2.58 μm axial (voxel volume: 12.14 μm3), enabling identification
of glomeruli, which were found to have a minimum volume of
2.4 104 μm3.
Our MF-HREM analysis measured 100 glomeruli per cubic
millimeter of kidney volume, with median glomeruli size of
1.88 105 μm3 and mean of 2.2 105 μm3. The number of
glomeruli per unit kidney volume is consistent with distributions
for wild-type adult mice conducted with light sheet[37]
(100140 glomeruli per mm3of kidney) and also MRI[36]
(74–90 glomeruli mm3of kidney). Our median size is also within
the bounds of those measured by lightsheet,[37] stereology, and
MRI.[36] This demonstrates the ability of MF-HREM to provide
accurate quantitative information on organotypic functional
units in adult mouse organs.
3.2. Imaging Tumor Blood Vessels and Cell Invasion
with MF-HREM
Widely reported hallmarks of cancer include deregulation of
angiogenesis and active invasion/metastasis.[38] Angiogenic
disruption is evident in solid tumors through highly complex
and disordered blood vessel networks. These networks are
responsible for the distribution of nutrients and drugs[3] and
are involved in bidirectional signaling that can stimulate cellular
invasion and, ultimately, lead to metastasis.[39] Multiplexed 3D
imaging of whole blood vessel networks with tumor cell invasion
can be used to interrogate the spatial relationship between
deregulated angiogenesis and cell invasion.
Figure 6 shows MF-HREM images from a subcutaneous
xenograft tumor mouse model initiated from the FaDu hypo-
pharyngeal cancer cell line, where both tumor cells and the blood
vessel network have been fluorescently labeled. Both stains are
clearly visible throughout the image stack (Figure 6A), and 3D
reconstruction of the entire dataset for both channels reveals
the dense, branching vasculature at the periphery of the tumor,
and the labeled cells primarily in the tumor center, which
appeared to be nonperfused due to an absence of the vascular
signal (Figure 6B). Single cells or cell clusters are also visible (yel-
low arrows in Figure 6A’s inset) in a section of tumor separate
from the main bulk. While it is unclear whether labeled cells are
viable (which would require a different reporter strategy), these
results demonstrate the ability of MF-HREM to quantify the 3D
location of injected cells in tissue volumes of 1 cm3 several
weeks after injection.
For the vascular imaging stain, Figure 6C,D shows a
subsection of the tumor vasculature that has been segmented
following image processing with our deconvolution approach.
The chaotic nature of the vasculature is clear from both the
appearance and the wide range of vessel sizes (Figure 6D).
Such segmented vascular networks can be used in simulations
of drug delivery[3] and for investigating tumor vessel growth
mechanism.[40]
3.3. Imaging Brain Microvasculature and White-Matter Tracts in
a Mouse Brain with MF-HREM
Healthy brain development and function is dependent upon the
intricate networks of both cerebrovascular and white-matter
fibers. Changes in the structures of these networks are key indi-
cators of a number of degenerative neurological diseases includ-
ing Alzheimer’s and Parkinson’s.[4]
Visualizing these structures in 3D with MF-HREM can be
used to improve our understanding of disease or potentially vali-
date in vivo imaging tools such as MRI.
Figure 7 shows the application of MF-HREM in two instances:
1) where a brain is dual labeled with CMDiI as a white-matter
marker and Lectin-Dyelight649 as a microvascular stain
(Figure 7AD) and 2) where a brain is dual labeled with
CMDiI as a white-matter marker and HCS NM as a marker
www.advancedsciencenews.com www.adpr-journal.com
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for cell distribution (Figure 7E,F). Figure 7B shows segmented
vasculature from the high-resolution subvolume of the
medulla. The observed microvasculature has a mean radius of
3.01 1.25 μm, with a large number of small vessels
(1.612 μm diameter) oriented parallel the brain surface and a
smaller number of larger (1222 μm diameter) descending arte-
rioles perpendicular to the brain surface (white arrows in
Figure 7B’s inset). This distribution is expected anatomically
and accords well with those measured by other serial-sectioning
modalities, e.g., MOST (2.82.4 μm for matched subregions),[41]
and for clearing techniques.[42] It should be noted that no large
vessels (>22 μm) are visible in MF-HREM data, likely due to the
preferential binding of lectin to microvasculature over larger ves-
sels as noted previously.[43]
An additional feature of interest in brain microstructure is
white-matter tract orientation. Previously, CMDiI has been used
Figure 5. Quantification of glomeruli number from the Lectin-Dyelight649 channel of a multistained murine kidney. A) From left to right, 2D slices
showing the unprocessed image, the segmented image produced by gradient vector flow algorithm, and finally, the manually corrected image after
removal of structures that were segmented (white/red arrows) but fall outside the kidney cortex (red line). Scale bars: 500 μm for all 2D slices.
B) 3D view of image processing. The original image stack with inset showing the detail which can be seen on the kidney surface (scale bar:
200 μm); then, the segmentation via gradient flow algorithm in Vaa3D[57–59] and manual exclusion of points not in the cortex. The final step is the
outcome of the connected components analysis and hence quantification of glomeruli number and volume distribution. These data show the expected
distribution and size of glomeruli for healthy weight mouse as compared with other techniques.[36,37]
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on histological sections of mouse brain to validate tractography
from diffusion-weighted (DW)-MR in 2D.[44] CMDiI effectively
stains white-matter tracts due to its lipophilic nature and can
be imaged with MF-HREM, allowing orientation analysis on
the 3D volumes. Figure 7D,F shows white-matter orientation
analysis for a small brain section and whole mouse brain, respec-
tively. Orientation is quantified by the structure tensor of the
image, which was estimated using the ImageJ plugin
OrientationJ.[45–47] The color bar shows the angle represented
by the hue.
Cell distribution and density are also important markers of
neurological development and pathology. Figure 7E shows a sin-
gle slice at a higher magnification from the imaging volume in
Figure 7F, and cell nuclei can be distinguished and demonstrate
that nuclear staining has successfully been retained throughout
processing. Further segmentation requires montaging of higher-
resolution images.
These data show that MF-HREM can be used in adult mouse
brain as a tool for visualizing vascular networks, white-matter
tracts, and cell distribution. Quantitative vessel analysis can be
conducted on higher-resolution data and orientation analysis
on whole brain images.
4. Conclusion
In this work, we have shown the development of sample prepa-
ration and image postprocessing in MF-HREM. We have dem-
onstrated its applicability in adult mouse organs through a range
of staining and quantification approaches.
Reducing the impact of subsurface fluorescence has been a
key factor in realizing the potential of MF-HREM. Our current
solution has combined two approaches: physically limit light
transmission through the sample and deconvolution in postpro-
cessing. Our deconvolution approach uses a sample-specific PSF,
whilst circumventing the problem of poor signal-to-noise that
would occur if the PSF is used directly from the image stack.
Likewise, our optimization of tissue-specific staining and embed-
ding protocols provides a solid foundation from which research-
ers hoping to apply this technique can build.
Further improvements to MF-HREM are possible in several
areas of the imaging pipeline. The resin embedding and staining
protocol can be improved by optimization to a specific biological
problem. For example, a custom mould can be used for repeated
preparation of similar samples. In addition, while dehydration
and embedding times cannot be easily decreased without
compromising the final imaging, automation of the process
using an automated histological sample processor could improve
consistency and enable faster protocol optimization for a specific
application.
Diffusion staining alone will always struggle to achieve
homogenous stain penetration in a timely manner. Even with
increased stain penetration via saponin treatment, inhomoge-
neous staining is evident. This challenge is common to all
whole-mount imaging techniques; thus, significant research
effort continues to be directed at overcoming this, e.g., the
use of nanobodies, genetically encoded reported, and perfusion
staining.[48–50]
The two interdependent approaches used here to circumvent
subsurface fluorescence could undergo more development to
widen MF-HREM application. To further reduce light
Figure 6. Xenograft tumor model analysis. A) A single representative slice with the two stains: CMDiI for injected cell tracking (white) and Lectin-Dyelight
649 conjugate for microvascular staining (magenta). The inset shows a digitally zoomed-in portion of the image where small, approximately circular
structures of cell size are indicated by yellow arrows. B) A 3D rendering of the two channels shows the tumor in its totality and the spatial arrangement of
the injected cells within the vascular network. The highly perfused rim can be clearly seen. The inset shows the same digitally zoomed section as the 2D
slice inset. C) Segmentation of a section of the vascular network following the PSF extraction described earlier. In this case the APP2 algorithm from the
Vaa3D neuron-tracing plug-in set was used to segment and skeletonize the deconvolved image stack.[57–60] D) The histogram of the vessel radii from C.
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transmission, alternative dyes could be incorporated into the
resin or shorter-wavelength incident light used.[51] Further
improvements to the deconvolution could be made through
more complex PSF models, for example, Gaussian mixture mod-
els[52] or spatially variant PSFs.[53]
Both optical clearing and serial-sectioning come with their
own specific challenges. Approaches which keep the sample
intact (thus requiring optical clearing) are limited in sample size
and resolution by the working distance of the microscope objec-
tive lens[2] and the need for broader light sheets to penetrate
greater tissue depth.[12] For applications where a serial-sectioning
approach would be better suited, uptake of serial-sectioning tech-
niques has been limited by the technicality of the custom-built
instruments,[15,54] leaving a niche for a robust, commercially
available serial-sectioning technique.
In this work, we developed a pipeline for conducting MF-
HREM, which enables 3D, multiplexed fluorescence imaging
of large tissue samples (>0.5 cm3), at high resolution. MF-
HREM is a block-facing technique, using a commercially
available system (Optical HREM, Indigo Scientific, UK),
that overcomes subsurface fluorescence, using a combination
of an opacifying agent and image deconvolution. This technique
Figure 7. MF-HREM of two brain samples, one stained with CMDiI Ex/Em 553/570 nm and Lectin-Dyelight 649 (Ex/Em 649/700) and a second stained
with CMDiI and HCS NM (Ex/Em 638/686). A) The volume overlay of both the CMDiI (Magenta) and the Lectin (yellow). Color bars show pixel intensity.
B) A high-resolution subvolume of the vasculature channel successfully segmented and skeletonized using the MF-HREM processing pipeline and the
MOST tracing algorithm implemented in Vaa3D. C) The histogram of radii distributions. D) The same subvolume in the CMDiI/white-matter channel;
here, an orientation analysis has been conducted via calculation of the structure tensor of the image using a Gaussian gradient and eight-pixel window
size. The hue, saturation, and brightness denote the orientation, coherence, and original image brightness, respectively. The color bar shows the angle
represented by the hue. E) A polar histogram of (D), where all orientations with a coherence greater than a threshold value of 0.2 are displaced. It can be
seen that there appears to be an even distribution of local orientations over this subvolume. F) Volume overlay of the CMDiI channel (white) and the HCS
NM channel (magenta) for a different brain sample. G) A single slice imaged at higher resolution in which nuclei can be clearly seen. H) Orientation of
white matter mapped over the whole brain. It was computed as in (D) but using a smaller window size of four pixels. The orientation can be seen to clearly
follow the expected white-matter tracts.
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can find wide applications through its avoidance of optical
sectioning, tissue clearing, or the need for a custom-built
instrument.
5. Experimental Section
Animal Models and Perfusion Fixation: All animal studies were licensed
under the UKHomeOffice regulations and the Guidance for the Operation
of Animals (Scientific Procedures) Act 1986 (HomeOffice, London, United
Kingdom) and United Kingdom Co-ordinating Committee on Cancer
Research Guidelines for the Welfare and Use of Animals in Cancer
Research.[55]
For perfusion fixation, animals were euthanized via intraperitoneal
(i.p.) injection of 100mg kg1 sodium pentobarbital (Animalcare,
Pentoject) diluted in 0.1 ml phosphate-buffered saline (PBS). Once anes-
thesia was confirmed, surgical procedures for cardiac perfusion were con-
ducted for systemic clearance of blood. Heparinized saline (20mL with
1000 IUmL1, maintained at 37 C) was administered with a perfusion
pump (Watson Marlow, 5058) at a flow rate of 3 mLmin1 to mimic nor-
mal blood flow. After the complete drainage of blood, mice were perfused
with 20ml of 4% paraformaldehyde (PFA, VWR chemicals 4 C). Organs
were then removed and fixed for 1224 h in 4% PFA at 4 C.
Stain Penetration: A total of 16 mice (N¼ 4) between 10 and 23 weeks
old of various strains were used. Mice were perfuse fixed as described ear-
lier and both kidneys were removed. Each animal was randomly assigned
to one of the four groups (saponin, freeze-thaw, iDISCO and proteinase [K]
digestion), and for each animal one kidney was randomly assigned to treat-
ment and the contralateral kidney retained as a matched control. In the
saponin, iDISCO, and proteinase [K] groups, the control kidney was main-
tained in PBS and at the same temperature as the treated kidney. For the
freeze-thaw group, the control kidney was dehydrated and rehydrated
through the same methanol series but with no freeze-thaw cycles applied.
Details of the timing and solutions composition for each of the four
groups are given in Supplementary Methods.
After treatment, all kidneys were stained for 94 h in 4ml of HCS NM
(Thermo Fisher UK) at a concentration of 4 μLmL1 in PBS at room tem-
perature with constant agitation. They were then bisected at the urethra,
and the cut surface was imaged on a glass-bottomed dish using the HREM
microscope (all imaging parameters were kept constant).
Resin Testing: Multiple candidate resins were tested for setting time,
compatibility with opacifying agents, final block hardness, and quality of cuts.
Resins used were Technovit 7100 (Heraeus Kulzer, Germany), Technovit
8100 (Heraeus Kulzer, Germany), Spurr resin (Polysciences Inc, USA), LR
White (Sigma-Aldrich, USA), and Lowicryl HM20 (Polysciences Inc, USA).
Composition of each resin is given in Supplementary Methods.
Hardness testing was conducted using either a Shore durometer D or
Shore durometer A on set blocks. Cut quality was assessed by imaging a
block with a mouse kidney embedded within it on the Optical HREM
(Indigo Scientific, UK) and quantifying the proportion of slices, which
had areas of flaky resin or voids and the severity of resin imperfection.
Waves vertical and horizontal were also incorporated into the cut quality
assessment.
Spectroscopy: The transmission spectrum of OB was measured using an
HG4000CG-UV-NIR (Ocean Optics) fiber-fed spectrometer. Samples of
Technovit 8100 base sol. plus catalyst 1, with a low concentration
(0.1 mgmL1) of OB, were measured in a polymethylmethacrylate
(PMMA) semimicro cuvette over a 4mm path length, from 350 to
95 nm with a QTH10/M (Thorlabs) continuum lamp. The transmission
spectrum (Figure 3C) was compensated for the cuvette reflectivity and
PMMA absorption.
Subsurface Fluorescence Quantification: Standard 3D cell cultures were
prepared as described (sup methods) and stained with HCS NM deep red
or HSC NM. Samples were prepared for HREM, as shown in Table 1, with
OB 45X (Stort Chemicals Ltd, Bishops Stortford, UK) mixed with Technovit
8100 at the last stage of resin infiltration (at concentrations of 2, 4, 8, 16,
and 32mgmL1) prior to positioning and setting the sample within the
final block.
Blocks were imaged over the full sample depth on the Optical HREM
system using slice thickness¼ 1.72 μm xy, pixel size¼ 0.57 μm, gain¼ 9
or 8, and exposure¼ 1.0 s or 0.6 s for the NM and CM samples, respec-
tively. Image stacks were downsampled in xy to create isotropic voxels,.
Image stacks were resliced into xz stacks (as shown in Figure 3C,D).
Ten ROIs were manually drawn around isolated cells per sample. The
ROIs were rectangular and fully enclosed all pixels with intensity above
the background. The intensity profile of the ROI was plotted (pixel intensity
vs z-direction). This signal was truncated at the maximum intensity and fit
to a single-exponential model (Equation (1)) in Matlab using a nonlinear
least squares approach with robust outlier elimination. Start values of 5000
for I0, 4000 for c, and between 0 and 1 for λ with limits  ∞ were used
(other start values used made no difference to final fit parameters where
the fit converged). The fits were used to quantify the change in subsurface
fluorescence.
I ¼ I0eλz þ c (1)
Image Postprocessing, PSF Fitting, and Deconvolution: HREM image
stacks were inherently aligned and hence were reconstructed as a volume
without any z-registration, alignment or overlap. Depending on the fluo-
rophores used for labeling and the excitation emission filters used in the
instrument, spectral unmixing (in the case of overlapping labeling spectra)
or background subtraction to remove autofluorescence (in the case of
shorter wavelength emission) may improve image appearance and aid
in further segmentation (Figure S2, Supporting Information).
For deconvolution, the PSF parameters were estimated from the image
stack as follows. The image stack was manually inspected for suitable
small structures; these were cropped from the stack and a 3D median
filtering with one pixel window size was applied to reduce noise.[56]
Line profiles through the small structures in x, y, and z were fit either with
a Gaussian (with offset in imageJ Fiji) or with an exponential decay from
which the FWHM in xy and z were calculated (model depended on pixel
size, see ST1 for details). A PSF was generated using with a Gaussian
model or a Gibson and Lanni model. For the Gibson and Lanni model,
the modeled wavelength and numerical aperture (NA) were iterated to
minimize the difference between the measured and modeled FWHM
(see Figure S2, Supporting Information, and Walsh et al.[11] for further
details of PSF fitting). The PSF was dependent on many factors including
but not limited to the wavelength of the fluorophore, the concentration of
the opacifying agent, and pixel size (zoom level) of the microscope. Final
PSF parameter values for each image stack with imaging parameters are
shown in Table S1, Supporting Information. In the final stage, the PSF was
made asymmetric (due to physical sectioning discussed) by setting the
lower half to zero and subtracting the background in the upper half (pixel
intensities less than 0.0001 in 32 bit images were zeroed). This PSF was
then used in a GPU-accelerated RL deconvolution algorithm[35] with border
size of one-fourth of the image stack in each dimension, respectively.
Optimization of iterations was based on orthogonality of structures
and contrast-to-noise ratio in the deconvolved final image stack.[11]
Murine Tumor Xenograft Model: About 810-week-old, female,
immune-compromised nu/nu nude mice (background CD1) were used
(Charles River Laboratories). Cells from the FaDu cell line (a hypopharyng-
eal cancer cell line gifted by Dr. Craig Murdoch [Sheffield University]) were
cultured in complete medium (Dulbecco’s minimum essential medium
Eagle with L-glutamine [DMEM] [Lonza]þ 10% fetal bovine serum
[Invitrogen]) in the ratio 1:10 (vol/vol) and incubated at 37 C and 5%
CO2. To prepare for injection, cells were washed with Dulbecco’s PBS
and detached with trypsin-EDTA (7–8 min, 37 C, 5% CO2) (Sigma).
Cells were labeled with CMDiI (Thermofisher UK), a medium-term fluo-
rescent cell-tracking dye that endures for 36 cell divisions, and was
transferred through cell division (but not cell–cell contact). Stain was dis-
solved from stock concentration (1mgmL1 in ethanol) in D-PBS to a
working solution of 1 μM. Cells were incubated in the working solution
for 5 min at 37 C and then for 15min at 4 C. Cells were then washed
and resuspended in PBS for injection. A 100 μl bolus of 1 106 cells
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was injected subcutaneously into the left flank above the hind leg of each
mouse (N¼ 5) and unstained cells were injected into the right flank also in
a 100 μl bolus of 1 106 cells. Tumor growth was measured daily with
calipers every day after the tumor became palpable and were grown until
total tumor volume was 1500mm3 or 3 weeks postinjection had elapsed.
For blood vessel staining, 200 μl lectin (“Tomato”) bound to DyeLyte-
649 (Vector UK) (1mgmL1) was administered via tail vein injection and
allowed to circulate for 10min before perfusion fixation to allow sufficient
binding to the vascular endothelium.[3]
Applications Segmentation: For each application, tumor, kidney, and
brain, an example segmentation for the biological structure of interests
was conducted to demonstrate the quantification potential of MF-
HREM data.
Glomeruli segmentation was conducted in Vaa3D (v3.601) using the
gradient vector flow algorithm,[57–59] with diffusion iteration of 5. This algo-
rithm is a widely used extension to a traditional active contour segmenta-
tion technique, where the external energy term in the traditional active
contour algorithm is replaced with the gradient vector flow field.
Manual segmentation of the kidney cortex was then conducted to remove
structures not within the cortex (i.e., not glomeruli). Finally, a connected
component analysis was conducted in Amira v 19.2 with a threshold max
size of 20 000 μm3. No deconvolution was necessary (as measured by
orthogonality ratio) due to the sizes of the structures of interest (glomer-
uli) relative to the pixel size.
For the tumor, following deconvolution (parameters in Table S1,
Supporting Information), vascular segmentation was conducted via the
APP2 algorithm of Vaa3D (v3.601).[57–60] Parameters were set as follows:
threshold¼1(autothresholding), CNN¼ 3, and Grey scale distance
transform (GSDT) and other parameters were used at their default values.
Brain microvasculature segmentation was conducted after deconvolu-
tion, semimanually in Amira-Avizo V 2019.2 using a 3D magic wand tool.
White-matter orientation analysis was conducted using the OrientationJ
plugin of Fiji[45–47] with a Gaussian gradient and kernel sizes of eight pixels
or four pixel for Figure 7D,F, respectively.
HREM Imaging: All MF-HREM imaging was conducted using the
Optical-HREM instrument (Indigo Scientific, UK), as shown in
Figure 1. Samples were prepared into blocks, as shown in Table 1.
Blocks were then mounted into the instrument and trimmed until a
flat-block surface perpendicular to the optical axis was created. Once this
surface was achieved, the desired slice thickness, x,y resolution, focus,
total imaging depth, and exposure and gain for each wavelength were
set. An air blower and vacuum were positioned to remove serial slices after
sectioning. Imaging then proceeded in a fully automated manner until the
total imaging depth was achieved. For each application, imaging param-
eters are shown in Table S1, Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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